Galliano D

No ORCID on file · 9 papers in corpus · active 2016-2026

Study types

  • review 3
  • article 2
  • other 1

Condition tags

  • adenomyosis 4
  • endometriosis 3
  • infertility 2
  • endometrioma 1
article 2026
Reproductive biomedicine online ·doi:10.1016/j.rbmo.2026.105499

RESEARCH QUESTION: What is the effect of adenomyosis on cumulative live birth rate (CLBR) in women undergoing single embryo transfer in donor-oocyte cycles, with specific attention to type, location and severity of disease. DESIGN: Retrosp…

review 2024
Journal of clinical medicine ·doi:10.3390/jcm13175224

This review article aims to summarize current tools used in the diagnosis of adenomyosis with relative pharmacological and surgical treatment and to clarify the relative association between adenomyosis and infertility, considering the impor…

2024
Journal of clinical medicine ·doi:10.3390/jcm13154333

A T-shaped uterus is a rare uterine malformation that is classically associated with diethylstilbesterol (DES) exposure. Surprisingly, the prevalence of T- and Y-shaped uterus has increased in recent years despite the absence of a diagnosti…

other 2024
Fertility and sterility ·doi:10.1016/j.fertnstert.2023.11.034

OBJECTIVE: To prospectively examine the association between adenomyosis type, location, and severity with reproductive outcomes in patients undergoing single embryo transfer (SET) with embryos derived from donor oocytes. DESIGN: A prospect…

2024
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-024-03275-7

PurposeMale infertility may influence fertilization rates, embryo morphology, and implantation rates in in vitro fertilization (IVF) cycles. Oocyte competence plays a major role in embryo development, but there is a limited understanding of…

article 2022
Reproductive biomedicine online ·doi:10.1016/j.rbmo.2022.09.023

RESEARCH QUESTION: Does aromatase inhibitor improve IVF outcomes by reducing local oestrogen production in patients with adenomyosis undergoing long-term gonadotrophin-releasing hormone agonist (GnRHa) treatment? DESIGN: Four patients with…

2020
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-020-00605-z

The prolonged lockdown of health services providing high-complexity fertility treatments -as currently recommended by many reproductive medicine entities- is detrimental for society as a whole, and infertility patients in particular. Global…

review 2020
Human Reproduction ·doi:10.1093/humrep/deaa337

Endometriosis requires medical management during a woman's reproductive years. Most treatments aim to create a hypoestrogenic milieu, but for patients wishing to conceive, drugs that allow normal ovarian function are needed. Targeting angio…

review 2016
Fertility and sterility ·doi:10.1016/j.fertnstert.2016.02.023

The authors review aberrations of uterine anatomy and physiology affecting pregnancy outcomes with IVF. In the case of endometriosis and hydrosalpinx, pathologies outside of the uterus alter the uterine endometrium. In the case of endometri…